-identify CSPH with VTCE & Plt
-VTCE15-20+plt <110
-VTCE 20-20+ plt < 150
-VTCE >20 + any plt
-NSBB for cACLD with CSPH
- Telepression+Albumin - 1st line for HRS-AKI
-Resp Failure Risks- ACLF3 & Hypoxia
#TLM25 @aasldnews.bsky.social
#StandUpforScience
#SaveHepBBirthdosw
#PatientCenteredCare
#TLM25
@aasldnews.bsky.social
@robbrierley.bsky.social
#HepBFoundation
#PatientVoice @aasldnews.bsky.social @worldhepalliance.bsky.social @lancetgastrohep.bsky.social
#PatientVoice @aasldnews.bsky.social @worldhepalliance.bsky.social @lancetgastrohep.bsky.social
⏳off all diuretics and medications for HE
📌happens in 1 out of 3 patients depending etiology
🖋️multiple factors affect it
🔎 improves survival and LR mortality
📍Risk of HCC remains the same: don’t stop screening
@anahitarabiee.bsky.social
#liversky
#TLM25
⏳off all diuretics and medications for HE
📌happens in 1 out of 3 patients depending etiology
🖋️multiple factors affect it
🔎 improves survival and LR mortality
📍Risk of HCC remains the same: don’t stop screening
@anahitarabiee.bsky.social
#liversky
#TLM25
FANTASTIC work by @drjessicadavis.bsky.social et al leading a controversy conference and consensus paper 👇🏼👇🏼👇🏼
Her beautiful graph won the cover photo 👌🏼
#liversky
#TLM25
@aasldnews.bsky.social
@ast-licop.bsky.social
FANTASTIC work by @drjessicadavis.bsky.social et al leading a controversy conference and consensus paper 👇🏼👇🏼👇🏼
Her beautiful graph won the cover photo 👌🏼
#liversky
#TLM25
@aasldnews.bsky.social
@ast-licop.bsky.social
Session by communication and technology committee
All brilliant speakers!
Proud to have served as the chair of this committee
@aasldnews.bsky.social
#TLM25
#liversky
@howardtleemd.bsky.social
Session by communication and technology committee
All brilliant speakers!
Proud to have served as the chair of this committee
@aasldnews.bsky.social
#TLM25
#liversky
@howardtleemd.bsky.social
A toast to you all with a delicious mocktail! Will see you around! Can’t wait!
#LiverTwitter @aasldnews.bsky.social
A toast to you all with a delicious mocktail! Will see you around! Can’t wait!
#LiverTwitter @aasldnews.bsky.social
Fantastic summary slide from @marurinella
#PostGraduateCourse #TLM25 @aasldnews.bsky.social
Fantastic summary slide from @marurinella
#PostGraduateCourse #TLM25 @aasldnews.bsky.social
Day 4 👟👟 #TLM25
@childrensnational.bsky.social @aasldnews.bsky.social #WashingtonDC #GrowthStudy
Day 4 👟👟 #TLM25
@childrensnational.bsky.social @aasldnews.bsky.social #WashingtonDC #GrowthStudy
We proudly recognized this year’s awardees and honorees at the #TLM25 Awards & Honors Gala. Join us in congratulating this incredible group of 2025 AASLD Distinguished Awardees! 👏👏
We proudly recognized this year’s awardees and honorees at the #TLM25 Awards & Honors Gala. Join us in congratulating this incredible group of 2025 AASLD Distinguished Awardees! 👏👏
Image & quote taken by Senior Correspondent, Larry Luxner.
#RareDisease #Hepatology #HepatocellularCarcinoma #MedSky
Image & quote taken by Senior Correspondent, Larry Luxner.
#RareDisease #Hepatology #HepatocellularCarcinoma #MedSky
#TLM25 @aasldnews.bsky.social
#TLM25 @aasldnews.bsky.social
@aasldnews.bsky.social | #TLM25
@aasldnews.bsky.social | #TLM25
From Nov 7–11, leaders in #Hepatology met in D.C. for @aasldnews.bsky.social's annual The Liver Meeting, sharing key research, patient insights, and innovations in care.
Catch Rare Disease Advisor’s top highlights ➡️ https://bit.ly/4axf17f
#RareDisease #LiverDisease #MedSky
From Nov 7–11, leaders in #Hepatology met in D.C. for @aasldnews.bsky.social's annual The Liver Meeting, sharing key research, patient insights, and innovations in care.
Catch Rare Disease Advisor’s top highlights ➡️ https://bit.ly/4axf17f
#RareDisease #LiverDisease #MedSky